Loading drug development pipeline…
Loading drug development pipeline…
Derived
For each drug, the most advanced stage supported by registered interventional trials and jurisdiction-aware approval records. Approval in any ingested jurisdiction outranks trial phase; a drug is counted once, at its highest stage.
Computedci-drug-pipeline-v1Stage rulesApprovals feed →
Funnel
Drugs reach Malignant Colon Neoplasm through trial conditions or approval indications mapped to it or to one of its descendant entities.
5 drugs · 35 active trials
Outside the funnel: Phase not stated 2. "Withdrawn" = every approval record for the scope is withdrawn or superseded; "phase not stated" = trials exist but none states a phase.
Data updated 13 hours agoSource updated unknownrecomputed with the intelligence layer
Drugs
Most advanced stage first, then most active trials. Trial counts are interventional studies linking the drug (and, when a cancer is selected, the cancer).
| Drug | Stage | Max phase | Active | Recruiting | Phase 3 | Total trials | Approvals | Jurisdictions | First approval | First trial |
|---|---|---|---|---|---|---|---|---|---|---|
| Rilotumumab | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | Oct 27, 2008 |
| Savolitinib | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | Jul 25, 2019 |
| Sulindac | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | 2006-03 |
| Topotecan | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | 2004-01 |
| Vinorelbine | Phase 2 | Phase 2 | 0 | 0 | 0 | 1 | 0 | — | — | Mar 1, 2018 |
| Adagrasib | Phase 1 | Phase 1 | 1 | 0 | 0 | 2 | 0 | — | — | Jul 28, 2021 |
| Selumetinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 3 | 0 | — | — | Dec 14, 2007 |
| Veliparib | Phase 1 | Phase 1 | 0 | 0 | 0 | 3 | 0 | — | — | 2010-10 |
| Carboplatin | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 2013-12 |
| Cediranib | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 2009-08 |
| Cisplatin | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | Nov 4, 2016 |
| Docetaxel | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 2004-06 |
| Lenalidomide | Phase 1 | Phase 1 | 0 | 0 | 0 | 2 | 0 | — | — | 2009-10 |
| Alisertib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2013-08 |
| Alvespimycin | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2004-07 |
| Buparlisib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2008-11 |
| Dacarbazine | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Dec 14, 2007 |
| Doxorubicin | Phase 1 | Early Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Nov 8, 2019 |
| Erlotinib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Dec 14, 2007 |
| Hyperthermic Intraperitoneal Chemotherapy | Phase 1 | Early Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Nov 8, 2019 |
| Interferon Alfacon-1 | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2013-07 |
| Luminespib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2011-02 |
| Motesanib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2004-12 |
| Nilotinib | Phase 1 | Early Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2016-05 |
| Paclitaxel | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2013-12 |
| Panobinostat | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2010-10 |
| Pazopanib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | 2009-12 |
| Samotolisib | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Nov 4, 2016 |
| Temsirolimus | Phase 1 | Phase 1 | 0 | 0 | 0 | 1 | 0 | — | — | Dec 14, 2007 |
| Decitabine | Phase not stated | N/A | 0 | 0 | 0 | 1 | 0 | — | — | 2013-07 |
| Ibuprofen | Phase not stated | N/A | 0 | 0 | 0 | 1 | 0 | — | — | 2013-02 |
Stages describe registered activity and ingested regulatory records, not efficacy. Only ingested jurisdictions (currently US and Canada) can place a drug at "approved"; trial phases are as registered by sponsors. Nothing here is a treatment recommendation.